Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 52.80
+1.72 (3.37%)
Jul 10, 2026, 3:00 PM CST
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 47.32 billion as of July 10, 2026. Its market cap has increased by 33.31% in one year.
Market Cap
47.32B
Enterprise Value
45.06B
Revenue
4.32B
Ranking
n/a
PE Ratio
16.00
Stock Price
52.80
Market Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 47.32B, an increase of 41.95%. That is a compound annual growth rate of 6.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 47.32B | 28.79% |
| Dec 31, 2025 | 36.74B | 178.10% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 73.13B |
| Shanghai Allist Pharmaceuticals | 54.99B |
| Asymchem Laboratories (Tianjin) | 53.49B |
| Pharmaron Beijing | 50.96B |
| Beijing Wantai Biological Pharmacy Enterprise | 35.11B |
| Suzhou Zelgen Biopharmaceuticals | 34.06B |
| Shanghai RAAS Blood Products | 29.77B |
| Chongqing Zhifei Biological Products | 27.79B |